50 employees
Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
2016
$20M
from 1 investors over 1 rounds
Jecure Therapeutics raised $20M on January 15, 2017
Investors: Versant Ventures